• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MICA reports strong year-end earnings

Article

Imaging services firm Medical Imaging Centers of America is hopingthat healthy financial results for its 1995 fiscal year (end-December)will help it stave off a shareholder insurgency scheduled to cometo a head this month. The brightest spot in San

Imaging services firm Medical Imaging Centers of America is hopingthat healthy financial results for its 1995 fiscal year (end-December)will help it stave off a shareholder insurgency scheduled to cometo a head this month.

The brightest spot in San Diego-based MICA's financial picturewas in net income. MICA reported net income for the year of $5.7million, much of which came as a one-time gain of $3.5 millionfrom the sale of the company's ultrasound and nuclear medicinedivision to Diagnostic Health Services. In 1994, MICA posted anet loss of $494,000.

MICA's revenue figures were lower, due in part to the lossof the ultrasound and nuclear medicine business. MICA had 1995sales of $43.2 million, compared with $55.4 million in 1994.

For the fourth quarter of 1995, MICA's revenues were $9.5 million,compared with $13.6 million in the same period the previous year.The firm had net income of $560,000, compared with a net lossof $949,000 in the same period the year before.

MICA believes the improved earnings figures are a sign thatthe company's business plan is working, according to chairmanand CEO Robert Muehlberg.

"Not only have we significantly reduced costs, but wehave also increased our volume on a same-center basis in marketsthat continue to be impacted by lower utilizations," he said.

Some of MICA's shareholders are not so sanguine, however. Agroup led by Steel Partners II of New York City claims that MICA'scurrent management has not provided enough shareholder value andthe group is trying to throw out MICA's board (SCAN 1/17/96).Steel Partners, which holds 19.7% of MICA's stock, has scheduleda shareholder meeting Feb. 26 to vote on its proposal.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.